Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The spleen is a secondary lymphoid organ situated in the upper left abdomen, divided into red pulp and white pulp regions, with an intervening marginal zone. The white pulp is rich in immune cells (B and T lymphocytes, dendritic cells); the red pulp filters blood, removing aged erythrocytes and pathogens. The spleen plays vital roles in the immune response, blood filtration, hematopoiesis during development, reservoir functions, and is involved in a number of disease processes such as infection, inflammation, and hematologic malignancies[1][2][3]. "Spleen tissue" itself is not a molecular target, but many components within it (such as receptors, cell surface proteins, and immune signaling molecules) serve as drug targets in immunology and hematology[1][2][3]. For any downstream data extraction, a more specific target (such as "CD4 molecule in spleen T cells" or "FDC in splenic germinal centers") should be used, rather than the whole organ or tissue.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spleen tissue.